1,577
Views
34
CrossRef citations to date
0
Altmetric
Articles

Perfluorooctanoic Acid (PFOA): Environmental Sources, Chemistry, Toxicology, and Potential Risks

, , &

References

  • Ahrens, L. 2011. Polyfluoroalkyl compounds in the aquatic environment: A review of their occurrence and fate. J. Environ. Monit. 13, 20–31. doi:10.1039/c0em00373e.
  • Apelberg, B. J., Witter, F. R., Herbstman, J. B., Calafat, A. M., Halden, R. U., Needham, L. L., and Goldman, L. R. 2007. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ. Health Perspect. 115, 1670–1676. doi:10.1289/ehp.10334.
  • ASTSWMO (Association of State and Territorial Solid Waste Management Officials). 2015. Perfluorinated chemicals (PFCs): Perfluoroctanoic acid (PFOA) & perfluorooctane sulfonate (PFOS). Information Paper. August 2015.
  • ATSDR (Agency for Toxic Substances and Disease Registry). 2017a. Perfluoroalkyl and polyfluoroalkyl substances (PFAS) in the U.S. population. https://www.atsdr.cdc.gov/pfc/docs/PFAS_in_People.pdf. August 21, 2017.
  • ATSDR (Agency for Toxic Substances and Disease Registry). 2017b. Perfluoroalkyl and polyfluoroalkyl Substances (PFAS) Frequently asked questions. https://www.atsdr.cdc.gov/pfc/docs/pfas_fact_sheet.pdf. August 22, 2017.
  • ATSDR (Agency for Toxic Substances and Disease Registry). 2018. Toxicological profile for perfluoroalkyls. Draft for Public Comment. June 2018.
  • Barry, V., Winquist, A., and Steenland, K. 2013. Perfluorooctanoic (PFOA) exposures and incident cancers among adults living near a chemical plant. Environ. Health Perspect. 121 (11–12), 1313–1318. doi:10.1289/ehp.1306615.
  • Bartell, S. M. 2017. Online serum PFOA calculator for adults. Environ. Health Perspect. 125 (10), 104502. doi:10.1289/EHP36.
  • Bartell, S. M., Calafat, A. M., Lyu, C., Kato, K., Ryan, B., and Steenland, K. 2010. Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia. Environ. Health Perspect. 118 (2), 222–228. doi:10.1289/ehp.0901252.
  • Betts, K. S. 2007. Perfluoroalkyl acids: What is the evidence telling us? Environ. Health Perspect. 115 (5), A250–A256. doi:10.1289/ehp.9021.
  • Bloom, M. S., Kannan, K., Spliethoff, H. M., Tao, L., Aldous, K. M., and Vena, J. E. 2010. Exploratory assessment of perfluorinated compounds and human thyroid function. Physiol. Behav. 99, 240–245. doi:10.1016/j.physbeh.2009.02.005.
  • Blum, A., Balan, S. A., Scheringer, M., Trier, X., Goldenman, G., Cousins, I. T., Diamond, M., Fletcher, T., Higgins, C., Lindeman, A. E., Peaslee, G., de Voogt, P., Wang, Z., and Weber, R. 2015. The Madrid Statement of poly- and perfluoroalkyl substances (PFASs). Environ. Health Perspect. 123 (5), A107–A111. doi:10.1289/ehp.1509934.
  • Buck, R. C., Franklin, J., Berger, U., Conder, J. M., Cousins, I. T., Voogt, P., Jensen, A. A., Kannan, K., Mabury, S. A., and vanLeeuwen, P. J. 2011. Perfluoroalkyl and polyfluoroalkyl substances in the environment: Terminology, classification, and origins. Integr. Environ. Assess Manag. 7, 513–541. doi:10.1002/ieam.258.
  • Butenhoff, J. L., Kennedy, G. L., Jr, Chang, S., and Olsen, G. W. 2012. Chronic dietary toxicity and carcinogenicity study with ammonium perfluorooctanoate in Sprague-Dawley rats. Toxicol. 298, 1–13. doi:10.1016/j.tox.2012.04.001.
  • C8 (C8 Science Panel). 2017. http://www.c8sciencepanel.org/index.html. Last updated January 4, 2017.
  • Calafat, A. M., Wong, L., Kuklenyik, Z., Reidy, J. A., and Needham, L. L. 2007. Polyfluoroalkyl chemicals in the U.S. population: Date from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and comparisons with NHANES 1999–2000. Environ. Health Perspect. 115, 1596–1602. doi:10.1289/ehp.10598.
  • Caverly Rae, J. M., Craig, L., Slone, T. W., Frame, S. R., Buxton, L. W., and Kennedy, G. L. 2015. Evaluation of chronic toxicity and carcinogenicity of ammonium 2,3,3,3-tetracluoro-2-(heptafluoropropoxy)-propanoate in Sprague-Dawley rats. Toxicol Rep. 2, 939–949. doi:10.1016/j.toxrep.2015.06.001.
  • CDC (Centers for Disease Control). 2018. Fourth National Report on Human Exposure to Environmental Chemicals. Updated tablesMarch 2018.
  • Conder, J. M., Hoke, R. A., De Wolf, W., Russell, M. H., and Buck, R. C. 2008. Are PFCAs bioaccumulative? A critical review and comparison with regulatory criteria and persistent lipophilic compounds. Environ. Sci. Technol. 42, 995–1003.
  • Costa, G., Sartori, S., and Consonni, D. 2009. Thirty years of medical surveillance in perfluooctanoic acid production workers. J. Occup. Environ. Med. 51, 364–372. doi:10.1097/JOM.0b013e3181965d80.
  • Darrow, L. A., Groth, A. C., Winquist, A., Shin, H., Bartell, S. M., and Steenland, K. 2016. Modeled perfluorooctanoic acid (PFOA) exposure and liver function in a Mid-Ohio Valley community. Environ. Health Perspect. 124, 1227–1233. doi:10.1289/ehp.1510391.
  • EFSA (European Food Safety Authority). 2008. Perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA) and their salts. Scientific opinion of the Panel on Contaminants in the Food Chain. Efsa J. 653, 1–131.
  • Emmett, E. A., Shofer, F. S., Zhang, H., Freeman, D., Desai, C., and Shaw, L. M. 2006. Community exposure to perfluorooctanoate: Relationships between serum concentrations and exposure sources. J. Occup. Environ. Med. 48 (8), 759–770. doi:10.1097/01.jom.0000232486.07658.74.
  • Federal Register (FR). 2016. Drinking water contaminant candidate list 4- Final. EPA-HQ-OW-2012-0217; FRL-9955-27-OW. Volume 81, No. 222, 81099–81114.
  • Fei, C., McLaughlin, J. K., Tarone, R. E., and Olsen, J. 2007. Perfluorinated chemicals and fetal growth: A study within the Danish National Birth Cohort. Environ. Health Perspect. 115, 1677–1682. doi:10.1289/ehp.10506.
  • Gallo, V., Leonardi, G., Genser, B., Lopez-Espinosa, M., Frisbee, S. J., Karlsson, L., Ducatman, A. M., and Fletcher, T. 2012. Serum perfluorooctanoate (PFOA) and perfluorooctane sulfate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure. Environ. Health Perspect. 120, 655–660. doi:10.1289/ehp.1104436.
  • Grandjean, P., Heilmann, C., Weihe, P., Nielsen, F., Mogensen, U. B., and Budtz-Jorgensen, E. 2017. Serum vaccine antibody concentrations in adolescents exposed to perfluorinated compounds. Environ. Health Perspect. doi:10.1289/EHP275.
  • HC (Health Canada). 2016. Perfluorooctanoic acid (PFOA) in drinking water. Document for public consultation. Prepared by the Federal-Provincial-Territorial Committee on Drinking Water, Ottawa, ON, Consultation period ends September 2, 2016.
  • Higgins, C. P. and Field, J. A. 2017. Our stainfree future? A virtual issue on poly- and perfluoroalkyl substances. Environ. Sci. Technol. 51, 5859–5860. doi:10.1021/acs.est.7b02575.
  • Hu, X. C., Andrews, D. Q., Lindstrom, A. B., Bruton, T. A., Schaider, L. A., Grandjean, P., Lohmann, R., Carignan, C. C., Blum, A., Balan, S. A., Higgins, C. P., and Sunderland, E. M. 2016. Detection of poly- and perfluoroalkyl substances (PFASs) in U.S. drinking water linked to industrial sites, military fire training areas, and wastewater treatment plants. Environ. Sci. Technol. Lett. 3 (10), 344–350. doi:10.1021/acs.estlett.6b00260.
  • IARC (International Agency for Research on Cancer). 2016. Perfluorooctanoic Acid, pp 74 ppgs, Lyon, France, IARC Monographs-110.
  • ITRC (Interstate Technology Regulatory Council). 2018. PFAS- Per- and Polyfluoroalkyl Substances. PFAS Fact Sheets. Accessed at https://pfas-1.itrcweb.org/fact-sheets/.
  • Johnson, P. I., Sutton, P., Atchley, D. S., Koustas, E., Lam, J., Sen, S., Robinson, K. A., Axelrad, D. A., and Woodruff, T. J. 2014. The Navigation Guide-Evidence-based medicine meets environmental health: Systematic review of human evidence for PFOA effects on fetal growth. Environ. Health Perspect. 122 (10), 1028–1039. doi:10.1289/ehp.1307893.
  • Kannan, K., Corsolini, S., Falandysz, J., Fillmann, G., Kumar, K. S., Loganathan, B. G., Mohd, M. A., Olivero, J., Van Wouwe, N., Yang, J. H., and Aldous, K. M. 2004. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ. Sci. Technol. 38, 4489–4495.
  • Kato, K., Wong, L., Jia, L. T., Kuklenyik, Z., and Calafat, A. M. 2011. Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 1999–2008. Environ. Sci. Technol. 45, 8037–8045. doi:10.1021/es1043613.
  • Kennedy, G. L., Butenhoff, J. L., Olsen, G. W., O’Connor, J. C., Seacat, A. M., Perkins, R. G., Biegel, L. B., Murphy, S. R., and Farrar, D. G. 2004. The toxicology of perfluorooctanoate. Crit. Rev. Toxicol. 34 (4), 351–384.
  • Klaunig, J. E., Hocevar, B. A., and Kamendulis, L. M. 2012. Mode of action analysis of perfluorooctanoic acid (PFOA) tumorigenicity and human relevance. Reproduct. Toxicol. 33, 410–418. doi:10.1016/j.reprotox.2011.10.014.
  • Koustas, E., Lam, J., Sutton, P., Johnson, P. I., Atchley, D. S., Sen, S., Robinson, K. A., Axelrad, D. A., and Woodruff, T. J. 2014. The navigation guide-evidence-based medicine meets environmental health: Systematic review of nonhuman evidence for PFOA effects on fetal growth. Environ. Health Perspect. 122, 1015–1027. doi:10.1289/ehp.1307177.
  • Krafft, M. P. and Riess, J. G. 2015. Per- and polyfluorinated substances (PFASs): Environmental Challenges. Curr. Opin. Colloid. Interface Sci. 20, 192–212. doi:10.1016/j.cocis.2015.07.004.
  • Kucharzyk, K. H., Darlington, R., Benotti, M., and Deeb, R. 2017. Novel treatment technologies for PFAS compounds: A critical review. J. Environ. Manage. 204, 757–764. doi:10.1016/j.jenvman.2017.08.016.
  • Lau, C. 2012. Perfluoroalkyl acids: Recent research highlights. Reprod. Toxicol. 33, 405–409. doi:10.1016/j.reprotox.2012.03.002.
  • Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., and Seed, J. 2007. Review-Perfuoroalkyl acids: A review of monitoring and toxicological findings. Toxicol. Sci. 99 (2), 366–394. doi:10.1093/toxsci/kfm128.
  • Lau, C., Thibodeauz, J. R., Hanson, R. G., Narotsky, M. G., Rogers, J. M., Lindstrom, A. B., and Strynar, M. J. 2006. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol. Sci. 90 (2), 510–518. doi:10.1093/toxsci/kfj105.
  • Lindstrom, A. B., Strynar, M. J., and Libelo, E. L. 2011. Polyfluorinated compounds: Past, present, and future. Environ. Sci. Technol. 45, 7954–7961. doi:10.1021/es2011622.
  • Liu, D., Xiu, Z., Liu, G., Wu, G., Adamson, D., Newell, C., Vikesland, P., Tsai, A., and Alvarez, P. J. 2013. Perfluorooctanoic acid degradation in the presence of Fe(III) under natural sunlight. J. Haz. Mater. 262, 456–463. doi:10.1016/j.jhazmat.2013.09.001.
  • Lou, I., Wambaugh, J. F., Lau, C., Hanson, R. G., Lindstrom, A. B., Strynar, M. J., Zehr, R. D., Setzer, R. W., and Barton, H. A. 2009. Modeling single and repeated dose pharmacokinetics of PFOA in mice. Toxicol. Sci. 107 (2), 331–341. doi:10.1093/toxsci/kfn234.
  • Maine CDC (Maine Center for Disease Control and Prevention). 2017. Summary of the 2016 Updates to the Maximum Exposure Guidelines. Augusta, ME, Department of Health and Human Services, Published January 10, 2017.
  • McNamara, J. D., Franco, R., Mimna, R., and Zappa, L. 2018. Comparison of activated carbons for removal of perfluorinated compounds from drinking water. J. AWWA. 110, 1. January 2018. doi:10.5942/jawwa.2018.110.0003.
  • MDEQ (Michigan Department of Environmental Quality). 2018. Table 1. Groundwater: Residential and Nonresidential, Part 201 Generic Cleanup Criteria and Screening Levels, Lansing, MI. June 25, 2018.
  • MDH (Minnesota Department of Health). 2017. Health based guidance for water. Toxicological Summary for: Perfluorooctanoic Acid. Web publication date: May 2017.
  • Melzer, D., Rice, N., Depledge, M. H., Henley, W. E., and Galloway, T. S. 2010. Associations between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey. Environ. Health Perspect. 118 (5), 686–692. doi:10.1289/ehp.0901584.
  • Moore, B. 2010. Overview of perfluorooctanoic acid. Proceedings of the Annual International Conference on Soils, Sediments, Water and Energy, Amherst, MA, Vol 12, Article 32.
  • Negri, E., Metruccio, F., Guercio, V., Tosti, L., Benfenati, E., Bonzi, R., La Vecchia, C., and Moretto, A. 2017. Exposure to PFOA and PFOS and fetal growth: A critical merging of toxicology and epidemiology data. Crit. Rev. Toxicol. 47 (6), 482–508. doi:10.1080/10408444.2016.1271972.
  • Netherlands National Institute for Public Health and the Environment (RIVM). 2016. Evaluation of substances used in the GenX technology by Chemours, Dordecht. RIVM Letter report 2016–0174. https://www.rivm.nl/dsresource?objectid=3186e480-7d66-4ded-ac59-acd2e804d3b5&type=org&disposition=inline.
  • NJDWQI (New Jersey Drinking Water Quality Institute). 2017. Maximum Contaminant Level Recommendation for Perfluorooctanoic Acid in Drinking Water, Trenton, NJ. March 15, 2017.
  • Nolan, L. A., Nolan, J. M., Shofer, F. S., Rodway, N. V., and Emmett, E. A. 2009. The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod. Toxicol. 27 (3–4), 231–238. doi:10.1016/j.reprotox.2008.11.001.
  • Nolan, L. W., Nolan, J. M., Shofer, F. S., Rodway, N. V., and Emmett, E. A. 2010. Congenital anomalies, labor/delivery complications, maternal risk factors and their relationship with perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod. Toxicol. 29 (2), 147–155. doi:10.1016/j.reprotox.2009.10.012.
  • NTP (National Toxicology Program). 2016. NTP Monograph. Immunotoxicity associated with exposure to perfluorooctanoic acid or perfluorooctane sulfonate. September 2016.
  • NY (New York). 2016. Governor Cuomo Announces Immediate State Action Plan to Address Contamination in Hoosick Falls, Governor’s Press Office, Albany, NY. January 27 2016.
  • Olsen, G. W., Burris, J. M., Burlew, M. M., and Mandel, J. H. 2003. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. Joem. 45 (3), 260–270.
  • Olsen, G. W., Mair, D. C., Lange, C. C., Harrington, L. M., Church, T. R., Goldberg, C. L., Herron, R. M., Hanna, H., Noiletti, J. B., Rios, J. A., Reagen, W. K., and Ley, C. A. 2017. Per- and polyfluoroalkyl substances (PFAS) in American Red Cross adult blood donors, 2000–2015. Environ. Res. 157, 87–95. doi:10.1016/j.envres.2017.05.013.
  • Perkins, R. G., Butenhoff, J. L., Kennedy, G. L., Jr, and Palazzolo, M. J. 2004. 13-Week dietary toxicity study of ammonium perfluorooctanoate (APFO) in male rats. Drug. Chem. Toxicol. 27 (4), 361–378. doi:10.1081/DCT-200039773.
  • Post, G. B., Cohn, P. D., and Cooper, K. R. 2012. Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: A critical review of recent literature. Environ. Res. 116, 93–117. doi:10.1016/j.envres.2012.03.007.
  • Post, G. B., Gleason, J. A., and Cooper, K. R. 2017. Key scientific issues in developing drinking water guidelines for perfluoroalkyl acids: Contaminants of emerging concern. PLoS Biol. December 20, 2017. doi:10.1371/journal.pbio.2002855.
  • Quist, E. M., Filgo, A. J., Cummings, C. A., Kissling, G. E., Hoenerhoff, M. J., and Fenton, S. E. 2015. Hepatic mitochondrial alteration in CD-1 mice associated with prenatal exposures to low doses of perfluorooctanoic acid (PFOA). Toxicol. Pathol. 43, 546–557. doi:10.1177/0192623314551841.
  • Shankar, A., Xiao, J., and Ducatman, A. 2011. Perfluoroalkyl chemicals and chronic kidney disease in U.S. adults. Am. J. Epidemiol. 174 (8), 893–900. doi:10.1093/aje/kwr171.
  • Son, H., Kim, S., Shin, H., Bae, H., and Yang, J. 2008. Perfluorooctanoic acid-induced hepatic toxicity following 21-day oral exposure in mice. Arch. Toxicol. 82, 239–246. doi:10.1007/s00204-007-0246-x.
  • Steenland, K., Fletcher, T., and Savitz, D. A. 2010. Epidemiologic evidence of the health effects of perfluorooctanoic acid (PFOA). Environ. Health Perspect. 118, 1100–1108. doi:10.1289/ehp.0901827.
  • Steenland, K., Jin, C., MacNeil, J., Lally, C., Ducatman, A., Vieira, V., and Fletcher, T. 2009. Predictors of PFOA levels in a community surrounding a chemical plant. Environ. Health Perspect. 117, 1083–1088. doi:10.1289/ehp.0800294.
  • Stein, C. R., Savitz, D. A., and Dougan, M. 2009. Serum levels of perfluorooctanoic acid and perfluorooctane sulfate and pregnancy outcome. Am. J. Epidemiol. 170 (7), 837–846. doi:10.1093/aje/kwp212.
  • Sun, M., Arevalo, E., Strynar, M., Lindstrom, A., Richardson, M., Kearns, B., Pickett, A., Smith, C., and Knappe, D. R. U. 2016. Legacy and emerging perfluoroalkyl substances are important drinking water contaminants in the Cape Fear River Watershed of North Carolina. Environ. Sci. Technol. Lett. 3, 415–419. doi:10.1021/acs.estlett.6b00398.
  • SWRCB (State Water Resources Control Board). 2016. Groundwater information sheet: Perfluorooctanoic acid (PFOA) & related compounds. http://www.swrcb.ca.gov/gama/docs/pfoa.pdf. Revised May 2016.
  • Teaf, C. M. and Covert, D. J. 2013. Perfluorinated compounds: Potentially applicable soil screening levels for the contaminant du jour. 29th Annual International Conference on Soils, Sediments, Water and Energy. Amherst, MA. October, 2013.
  • Tucker, D. K., Macon, M. B., Strynar, M. J., Dagnino, S., Anderson, E., and Fenton, S. E. 2015. The mammary gland is a sensitive pubertal target in CD-1 and C57B1/6 mice following perinatal perfluorooctanoic acid (PFOA) exposure. Reprod. Toxicol. 54, 26–36. doi:10.1016/j.reprotox.2014.12.002.
  • USEPA (United States Environmental Protection Agency). 2009a. Provisional Health Advisories for Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS), Washington, DC. January 8, 2009.
  • USEPA (United States Environmental Protection Agency). 2009b. Method 537. Determination of selected perfluorinated alkyl acids in drinking water by solid phase extraction and liquid chromatography/tandem mass spectrometry (LC/MS/MS). EPA/600/R-08/092. September 2009.
  • USEPA (United States Environmental Protection Agency). 2012. The third unregulated contaminant monitoring rule (UCMR 3), Searching for emerging contaminants in drinking water. EPA 815-F-12-002. Office of Water. May 2012.
  • USEPA (United States Environmental Protection Agency). 2016a. Drinking water health advisory for Perfluorooctanoic Acid (PFOA). EPA 822-R-16-005. May 2016.
  • USEPA (United States Environmental Protection Agency). 2016b. Health effects support document for Perfluorooctanoic Acid (PFOA). EPA 822-R-16-003. May 2016.
  • USEPA (United States Environmental Protection Agency). 2016c. Fact sheet: PFOA & PFOS drinking water health advisories. EPA 800-F-16-003. November 2016.
  • USEPA (United States Environmental Protection Agency). 2017. Technical fact sheet- Perfluorooctane Sulfonate (PFOS) and Perfluorooctanoic Acid (PFOA). EPA 505-F-17-001. Office of Land and Emergency Management. November 2017.
  • USEPA (United States Environmental Protection Agency). 2018a. PFAS national leadership summit materials. https://www.epa.gov/pfas/pfas-national-leadership-summitmaterials.
  • USEPA (United States Environmental Protection Agency). 2018b. Fact Sheet: Draft Toxicity Assessments for GenX Chemicals and PFBS, Washington, DC. November 2018.
  • VDOH (VT Department of Health). 2016. Facts about PFOA for concerned residents. http://www.healthvermont.org/sites/default/files/documents/2016/12/Env_DW_PFOA_health_facts.pdf. 11 April 2016.
  • Vierke, L., Staude, C., Biegel-Engler, A., Drost, W., and Schulte, C. 2012. Perfluorooctanoic acid (PFOA)-main concerns and regulatory developments in Europe from an environmental point of view. Environ. Sci. Europe. 24 (16), 11. doi:10.1186/2190-4715-24-16.
  • Wang, Z., DeWitt, J. C., Higgins, C. P., and Cousins, I. T. 2017. A never-ending story of per- and Polyfluoroalkyl Substances (PFASs)? Environ. Sci. Technol. 51 (5), 2508–2518. doi:10.1021/acs.est.6b04806.
  • Watkins, D., Josson, J., Elston, B., Bartell, S. M., Shin, H., Vieira, V. M., Savitz, D. A., Fletcher, T., and Welleniius, G. A. 2013. Exposure to perfluoroalkyl acids and markers of kidney function among children and adolescents living near a chemical plant. Environ. Health Perspect. 121, 625–630. doi:10.1289/ehp.1205838.
  • Wu, X., Bennett, D. H., Calafat, A. M., Kato, K., Strynar, M., Andersen, E., Moran, R. E., Tancredi, D. J., Tulve, N. S., and Hertz-Picciotto, I. 2015. Serum concentrations of perfluorinated compounds (PFC) among selected populations of children and adults in California. Environ. Res. 136, 267–273. doi:10.1016/j.envres.2014.09.026.
  • Xiao, L., Ling, Y., Alsbaiee, A., Li, C., Helbling, D. E., and Dichtel, W. R. 2017. B-cyclodextrin polymer network sequesters perfluorooctanoic acid at environmentally relevant concentrations. J. Am. Chem. Soc. 139, 7689–7692. doi:10.1021/jacs.7b02381.
  • Yamashita, N., Kannan, K., Taniyasu, S., Horii, Y., Petrick, G., and Gamo, T. 2005. A global survey of perfluorinated acids in oceans. Marine Poll. Bull. 51, 658–668. doi:10.1016/j.marpolbul.2005.04.026.
  • Zushi, Y., Hogarh, J. N., and Masunaga, S. 2012. Progress and perspective of perfluorinated compound risk assessment and management in various countries and institutes. Clean Technol. Environ. Policy. 14, 9–20. doi:10.1007/s10098-011-0375-z.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.